| BEN |
Report |
Adjusted EPS |
BEAT |
pred ~$0.67 vs. cons $0.66 |
MEDIUM |
| BEN |
Report |
Adjusted operating margin |
IN-LINE |
pred ~26.6% vs. cons 26.4% |
MEDIUM |
| BEN |
Report |
Effective investment-management fee rate |
IN-LINE |
pred ~37.8 bps vs. cons 37.7 bps |
HIGH |
| BEN |
Guide |
Adjusted operating margin |
BETTER |
guide ~29.5% vs. cons 29.3% (fiscal Q4 2026) |
MEDIUM |
| BEN |
Guide |
Adjusted compensation expense |
BETTER |
guide ~$825M vs. cons $830M (fiscal Q4 2026) |
LOW |
| BEN |
Guide |
Private-markets fundraising |
BETTER |
guide ~$35B vs. cons $33B (fiscal 2026) |
MEDIUM |
| BEN |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.2% |
— |
MEDIUM |
| BEN |
Return |
5-day cumulative residual |
+0.3% (FADE) |
The modest EPS beat should be largely attributable to already-disclosed AUM and flows. Unless Q4 margin guidance rises materially above the high-29% range, out-period EPS revisions should be smaller than the reported-quarter beat; elevated fundraising costs and new retention compensation also limit fiscal-2027 estimate upside, causing most of the initial gain to fade. |
MEDIUM |